Next-generation antibody therapies, such as bispecific antibodies, nanobodies, and antibody-drug conjugates, guarantee to provide brand-new options for contagious diseases, autoimmune conditions, cancer, and beyond. As scientists press the limitations of antibody therapies, they require fast, automated workflows for screening, separating, and assaying antibody-secreting cells. New innovation permits researchers to assay thousands of single main antibody-secreting cells in just one day.Download this ebook from Satorius to learn aboutNew prospects for monoclonal antibody therapiesTraditional and modern-day methods for antibody seclusion Rapid primary B cell analysis with the CellCelector Flex automated platformSponsored by